Squamous cell cancer of the x-ulx a is a rarely encountered disease. accounting for 4c%-of all gxnaecological malignancies. When diagnosed wxith vulvar cancer in an earlv stage of the disease, patients general1v enjov a faxourable prognosis. % ith 5-x ear survxial rates of 80-90%f/ (Hacker et al. 1994 ). Howxever. a small subset of patients suffering from early-stage i-ulx ar cancer are still at risk for recurrence. Additional prognostic factors may be useful to identifx this subgroup of high-risk patients. thus makinc them eligible for close follow--up schemes or adjux ant therapy.
The transmembrane receptor protein CD44 belongs to the familv of cell-surface adhesion molecules mediatinc cell-cell and cell-matrix interactions (Underhill et al. 1992) . CD44 is inxolxed in lymphocyte functions such as cell actixation. motility. division. adhesion to extracellular matrix and adhesion to stromal cells (Mackax et al. 19941. CD44 proteins are encoded by a gene located on chromosome 11. The CD44 gene comprises 19 exons.
nine of w-hich may be alternatively spliced to form additional amino acids in the extracellular domain of the CD44 protein (Screaton et al. 1992 ). Aberrant expression of CD44 isoforms. e.g. . indicates a loss of splice control in malianantlv transformed cells (Salles et al. 1993) .
It has been show-n that the expression of CD44 isoforms is associated with metastasis and poor prognosis in human malignancies such as breast cancer. colorectal cancer and gastrointestinal lvmphoma (Joensuu et al. 1993 : Mulder et al. 1994 : Kauffmann et al. 1995 
Statistics
The chi-square test was used when appropriate. Survival probabilities were calculated by the product limit method of Kaplan and Meier (Kaplan and Meier. 1958) . Differences between groups were tested using the log-rank test. The results were analysed for the end point of os erall and relapse-free survival. Survival times of patients still alive or relapse-free were censored with the last follow-up date. P-values < 0.05 were considered statistically significant. The Kendall Tau b-correlation coefficient was used to assess the correlation between the expression of different CD44 isoforms. The BMDP British Joumal of Cancer (1998) 78(8) Figure 1) . CD44v3 expression was found in patients with and without recurrence in 12 and 8 cases respectively. Patients suffering from tumours expressing CD44v3 had a poorer relapse-free (log-rank test. P = 0.04) and overall survival (log-rank test. P = 0.01. Figure 2) .
Survival analysis for the whole population showed no significant prognostic value for CD44v5 (log-rank test. P = 0.8. Figure 3) and CD44v7-8 (log-rank test. P = 0.9. Figure 4) . Correlation coefficients for CD44v3/CD44v5. CD44v3/CD44v6. CD44v3/CD44v7-8. CD44v5/CD44v6. CD44v5/CD44v7-8 and CD44v6/CD44v7-8 were 0.24. 0.01. 0.11. 0.21. 0.12 and 0.05 respectively.
Patients with poorly differentiated tumours had a shorter overall survival than patients with moderately and highly differentiated tumours (log-rank test. P = 0.02). We found no correlation between the expression of CD44 isoforms and histological grade of the tumours. variant exons has been shown to be associated with poor prognosis in human malignancies. e.g. breast. cervical and colorectal cancer (Mulder et al. 1994 : Kainz et al. 1995 : Kauffmann et al. 1995 al (1996) have reported PFSR to be strongly correlated with high CD44 expression. Therefore. it may be hypothesized that CD44 plays a role in vulvar tumorigenesis by altering the hyaluronate metabolism of the vulvar stroma.
In our series vulvar cancer samples showed frequent expression of CD44v3. CD44vS and CD44v6. whereas CD44v7-8 was only expressed in a small number of cases. This expression pattern is in accordance with previously reported data on squamous cell carcinomas of the cervix (Kainz et al. 1995) .
In all our specimens we obserned a membrane-bound staining pattern for all four investigated CD44 isoforms. This observation is in accordance with previously reported data on CD44 stainingy pattems in other human malignomas (Salmi et al. 1993 : Kainz et al. 1995 . The immunohistochemical approach of detecting CD44 expression must be viewed with care because of possible underestimation of membrane molecule expression as a result of embedding procedures. However. in recent studies an excellent correlation between the detection of CD44 isoforms by immrunohistochemistrs and reverse transcription PCR was reported (Dall et al. 1995 (Tempfer et al. 1996a. b) . It has to be stated that a total of nine patients described in these previous studies are also incorporated in the present Investigation. The aim of the present study was to evaluate whether CD44 isoform expression may be used as an adverse prognosticator in a homogeneous collective of patients with early-stage vulvar cancer.
We were able to show that expression of CD44 isoforms containing variant exons v6 or v3 is correlated with a poor prognosis. Patients whose tumours revealed expression of CD44v6 or CD44v3 showed a significantly poorer overall and relapse-free survival.
These data indicate that CD44 isoform expression is an early event in vulvar carcinogenesis. It is a shortcoming of this study that, because of the study period before the introduction of a surgical staging system by FIGO in 1988 (Anonymous. 1989 . no groin dissection was performed. Therefore it cannot be ruled out that micrometastases may have been present in patients included in the study. This has to be taken into account when interpreting the results of this study.
The assessment of CD44 isoform expression could be of clinical value in selecting patients for close follow-up schemes or in deciding about adjuvant therapy in patients suffering from low-stage vulvar cancer. In summary. the results of this preliminary study indicate that the evaluation of CD44 expression may be helpful in individualizing the management of early-stage vulvar cancer.
